{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:39:38Z","timestamp":1759963178449},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,11,7]],"date-time":"2005-11-07T00:00:00Z","timestamp":1131321600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Peroxisome proliferator-activated receptor (PPAR) \u03b1, \u03b2\u03b4 and \u03b3 are nuclear receptors activated by fatty acid metabolites. An anti-inflammatory role for these receptors in airway inflammation has been suggested.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Nasal biopsies were obtained from 10 healthy volunteers and 10 patients with symptomatic allergic rhinitis. Nasal polyps were obtained from 22 patients, before and after 4 weeks of local steroid treatment (fluticasone). Real-time RT-PCR was used for mRNA quantification and immunohistochemistry for protein localization and quantification.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>mRNA expression of PPAR\u03b1, PPAR\u03b2\u03b4, PPAR\u03b3 was found in all specimens. No differences in the expression of PPARs were obtained in nasal biopsies from patients with allergic rhinitis and healthy volunteers. Nasal polyps exhibited lower levels of PPAR\u03b1 and PPAR\u03b3 than normal nasal mucosa and these levels were, for PPAR\u03b3, further reduced following steroid treatment. PPAR\u03b3 immunoreactivity was detected in the epithelium, but also found in smooth muscle of blood vessels, glandular acini and inflammatory cells. Quantitative evaluation of the epithelial immunostaining revealed no differences between nasal biopsies from patients with allergic rhinitis and healthy volunteers. In polyps, the PPAR\u03b3 immunoreactivity was lower than in nasal mucosa and further decreased after steroid treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The down-regulation of PPAR\u03b3, in nasal polyposis but not in turbinates during symptomatic seasonal rhinitis, suggests that PPAR\u03b3 might be of importance in long standing inflammations.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1465-9921-6-132","type":"journal-article","created":{"date-parts":[[2005,11,8]],"date-time":"2005-11-08T07:16:31Z","timestamp":1131434191000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Downregulation of peroxisome proliferator-activated receptors (PPARs) in nasal polyposis"],"prefix":"10.1186","volume":"6","author":[{"given":"Lars-Olaf","family":"Cardell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"H\u00e4gge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Uddman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikael","family":"Adner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,11,7]]},"reference":[{"key":"370_CR1_370","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1159\/000236855","volume":"106","author":"D Wang","year":"1995","unstructured":"Wang D, Clement P, Smitz J, De Waele M, Derde MP: Correlations between complaints, inflammatory cells and mediator concentrations in nasal secretions after nasal allergen challenge and during natural allergen exposure.\nInt Arch Allergy Immunol 1995, 106:278\u2013285.","journal-title":"Int Arch Allergy Immunol"},{"key":"370_CR2_370","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1007\/BF02484434","volume":"252 Suppl 1","author":"C Bachert","year":"1995","unstructured":"Bachert C, Hauser U, Prem B, Rudack C, Ganzer U: Proinflammatory cytokines in allergic rhinitis.\nEur Arch Otorhinolaryngol 1995, 252 Suppl 1:S44\u20139.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"370_CR3_370","doi-asserted-by":"publisher","first-page":"S763","DOI":"10.1016\/S0091-6749(97)70125-8","volume":"99","author":"JN Baraniuk","year":"1997","unstructured":"Baraniuk JN: Pathogenesis of allergic rhinitis.\nJ Allergy Clin Immunol 1997, 99:S763\u201372.","journal-title":"J Allergy Clin Immunol"},{"key":"370_CR4_370","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1046\/j.1365-2222.2003.01682.x","volume":"33","author":"J Kinhult","year":"2003","unstructured":"Kinhult J, Egesten A, Benson M, Uddman R, Cardell LO: Increased expression of surface activation markers on neutrophils following migration into the nasal lumen.\nClin Exp Allergy 2003, 33:1141\u20131146.","journal-title":"Clin Exp Allergy"},{"key":"370_CR5_370","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00130832-200302000-00001","volume":"3","author":"R Pawankar","year":"2003","unstructured":"Pawankar R: Nasal polyposis: an update: editorial review.\nCurr Opin Allergy Clin Immunol 2003, 3:1\u20136.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"370_CR6_370","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1046\/j.1365-2222.2001.01045.x","volume":"31","author":"M Benson","year":"2001","unstructured":"Benson M, Adner M, Cardell LO: Cytokines and cytokine receptors in allergic rhinitis: how do they relate to the Th2 hypothesis in allergy?\nClin Exp Allergy 2001, 31:361\u2013367.","journal-title":"Clin Exp Allergy"},{"key":"370_CR7_370","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.otohns.2003.12.022","volume":"130","author":"JM Bernstein","year":"2004","unstructured":"Bernstein JM, Ballow M, Rich G, Allen C, Swanson M, Dmochowski J: Lymphocyte subpopulations and cytokines in nasal polyps: is there a local immune system in the nasal polyp?\nOtolaryngol Head Neck Surg 2004, 130:526\u2013535.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"370_CR8_370","first-page":"91","volume":"11","author":"CA Dinarello","year":"1997","unstructured":"Dinarello CA: Role of pro- and anti-inflammatory cytokines during inflammation: experimental and clinical findings.\nJ Biol Regul Homeost Agents 1997, 11:91\u2013103.","journal-title":"J Biol Regul Homeost Agents"},{"key":"370_CR9_370","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1161\/01.CIR.101.11.1311","volume":"101","author":"RE Law","year":"2000","unstructured":"Law RE, Goetze S, Xi XP, Jackson S, Kawano Y, Demer L, Fishbein MC, Meehan WP, Hsueh WA: Expression and function of PPARgamma in rat and human vascular smooth muscle cells.\nCirculation 2000, 101:1311\u20131318.","journal-title":"Circulation"},{"key":"370_CR10_370","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1001\/archderm.136.5.609","volume":"136","author":"CN Ellis","year":"2000","unstructured":"Ellis CN, Varani J, Fisher GJ, Zeigler ME, Pershadsingh HA, Benson SC, Chi Y, Kurtz TW: Troglitazone improves psoriasis and normalizes models of proliferative skin disease: ligands for peroxisome proliferator-activated receptor-gamma inhibit keratinocyte proliferation.\nArch Dermatol 2000, 136:609\u2013616.","journal-title":"Arch Dermatol"},{"key":"370_CR11_370","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/00054725-200209000-00004","volume":"8","author":"LJ Saubermann","year":"2002","unstructured":"Saubermann LJ, Nakajima A, Wada K, Zhao S, Terauchi Y, Kadowaki T, Aburatani H, Matsuhashi N, Nagai R, Blumberg RS: Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis.\nInflamm Bowel Dis 2002, 8:330\u2013339.","journal-title":"Inflamm Bowel Dis"},{"key":"370_CR12_370","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/347645a0","volume":"347","author":"I Issemann","year":"1990","unstructured":"Issemann I, Green S: Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators.\nNature 1990, 347:645\u2013650.","journal-title":"Nature"},{"key":"370_CR13_370","doi-asserted-by":"publisher","first-page":"7355","DOI":"10.1073\/pnas.91.15.7355","volume":"91","author":"SA Kliewer","year":"1994","unstructured":"Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, Mangelsdorf DJ, Umesono K, Evans RM: Differential expression and activation of a family of murine peroxisome proliferator-activated receptors.\nProc Natl Acad Sci U S A 1994, 91:7355\u20137359.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"370_CR14_370","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/endo.137.1.8536636","volume":"137","author":"O Braissant","year":"1996","unstructured":"Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W: Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat.\nEndocrinology 1996, 137:354\u2013366.","journal-title":"Endocrinology"},{"key":"370_CR15_370","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/384039a0","volume":"384","author":"PR Devchand","year":"1996","unstructured":"Devchand PR, Keller H, Peters JM, Vazquez M, Gonzalez FJ, Wahli W: The PPARalpha-leukotriene B4 pathway to inflammation control.\nNature 1996, 384:39\u201343.","journal-title":"Nature"},{"key":"370_CR16_370","doi-asserted-by":"publisher","first-page":"46260","DOI":"10.1074\/jbc.M107180200","volume":"276","author":"T Hatae","year":"2001","unstructured":"Hatae T, Wada M, Yokoyama C, Shimonishi M, Tanabe T: Prostacyclin-dependent apoptosis mediated by PPAR delta.\nJ Biol Chem 2001, 276:46260\u201346267.","journal-title":"J Biol Chem"},{"key":"370_CR17_370","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/0092-8674(95)90193-0","volume":"83","author":"BM Forman","year":"1995","unstructured":"Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM: 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma.\nCell 1995, 83:803\u2013812.","journal-title":"Cell"},{"key":"370_CR18_370","first-page":"665","volume":"97","author":"C Duval","year":"2004","unstructured":"Duval C, Fruchart JC, Staels B: PPAR alpha, fibrates, lipid metabolism and inflammation.\nArch Mal Coeur Vaiss 2004, 97:665\u2013672.","journal-title":"Arch Mal Coeur Vaiss"},{"key":"370_CR19_370","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1161\/01.HYP.0000113626.76571.5b","volume":"43","author":"WA Hsueh","year":"2004","unstructured":"Hsueh WA, Bruemmer D: Peroxisome proliferator-activated receptor gamma: implications for cardiovascular disease.\nHypertension 2004, 43:297\u2013305.","journal-title":"Hypertension"},{"key":"370_CR20_370","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nrc1254","volume":"4","author":"L Michalik","year":"2004","unstructured":"Michalik L, Desvergne B, Wahli W: Peroxisome-proliferator-activated receptors and cancers: complex stories.\nNat Rev Cancer 2004, 4:61\u201370.","journal-title":"Nat Rev Cancer"},{"key":"370_CR21_370","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/nri912","volume":"2","author":"RA Daynes","year":"2002","unstructured":"Daynes RA, Jones DC: Emerging roles of PPARs in inflammation and immunity.\nNat Rev Immunol 2002, 2:748\u2013759.","journal-title":"Nat Rev Immunol"},{"key":"370_CR22_370","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1084\/jem.20021384","volume":"198","author":"G Woerly","year":"2003","unstructured":"Woerly G, Honda K, Loyens M, Papin JP, Auwerx J, Staels B, Capron M, Dombrowicz D: Peroxisome proliferator-activated receptors alpha and gamma down-regulate allergic inflammation and eosinophil activation.\nJ Exp Med 2003, 198:411\u2013421.","journal-title":"J Exp Med"},{"key":"370_CR23_370","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/sj.bjp.0705232","volume":"139","author":"A Trifilieff","year":"2003","unstructured":"Trifilieff A, Bench A, Hanley M, Bayley D, Campbell E, Whittaker P: PPAR-alpha and -gamma but not -delta agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF-kappaB-independent effect.\nBr J Pharmacol 2003, 139:163\u2013171.","journal-title":"Br J Pharmacol"},{"key":"370_CR24_370","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1164\/ajrccm.164.8.2101070","volume":"164","author":"L Benayoun","year":"2001","unstructured":"Benayoun L, Letuve S, Druilhe A, Boczkowski J, Dombret MC, Mechighel P, Megret J, Leseche G, Aubier M, Pretolani M: Regulation of peroxisome proliferator-activated receptor gamma expression in human asthmatic airways: relationship with proliferation, apoptosis, and airway remodeling.\nAm J Respir Crit Care Med 2001, 164:1487\u20131494.","journal-title":"Am J Respir Crit Care Med"},{"key":"370_CR25_370","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1165\/ajrcmb.24.6.4376","volume":"24","author":"AC Wang","year":"2001","unstructured":"Wang AC, Dai X, Luu B, Conrad DJ: Peroxisome proliferator-activated receptor-gamma regulates airway epithelial cell activation.\nAm J Respir Cell Mol Biol 2001, 24:688\u2013693.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"370_CR26_370","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/34178","volume":"391","author":"M Ricote","year":"1998","unstructured":"Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK: The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation.\nNature 1998, 391:79\u201382.","journal-title":"Nature"},{"key":"370_CR27_370","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/35154","volume":"391","author":"C Jiang","year":"1998","unstructured":"Jiang C, Ting AT, Seed B: PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines.\nNature 1998, 391:82\u201386.","journal-title":"Nature"},{"key":"370_CR28_370","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jaci.2004.02.036","volume":"113","author":"K Honda","year":"2004","unstructured":"Honda K, Marquillies P, Capron M, Dombrowicz D: Peroxisome proliferator-activated receptor gamma is expressed in airways and inhibits features of airway remodeling in a mouse asthma model.\nJ Allergy Clin Immunol 2004, 113:882\u2013888.","journal-title":"J Allergy Clin Immunol"},{"key":"370_CR29_370","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.4049\/jimmunol.170.5.2663","volume":"170","author":"HJ Patel","year":"2003","unstructured":"Patel HJ, Belvisi MG, Bishop-Bailey D, Yacoub MH, Mitchell JA: Activation of peroxisome proliferator-activated receptors in human airway smooth muscle cells has a superior anti-inflammatory profile to corticosteroids: relevance for chronic obstructive pulmonary disease therapy.\nJ Immunol 2003, 170:2663\u20132669.","journal-title":"J Immunol"},{"key":"370_CR30_370","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1677\/joe.0.1690453","volume":"169","author":"P Delerive","year":"2001","unstructured":"Delerive P, Fruchart JC, Staels B: Peroxisome proliferator-activated receptors in inflammation control.\nJ Endocrinol 2001, 169:453\u2013459.","journal-title":"J Endocrinol"},{"key":"370_CR31_370","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1002\/1521-4141(200104)31:4<1098::AID-IMMU1098>3.0.CO;2-I","volume":"31","author":"SG Harris","year":"2001","unstructured":"Harris SG, Phipps RP: The nuclear receptor PPAR gamma is expressed by mouse T lymphocytes and PPAR gamma agonists induce apoptosis.\nEur J Immunol 2001, 31:1098\u20131105.","journal-title":"Eur J Immunol"},{"key":"370_CR32_370","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0014-5793(00)02319-X","volume":"486","author":"C Faveeuw","year":"2000","unstructured":"Faveeuw C, Fougeray S, Angeli V, Fontaine J, Chinetti G, Gosset P, Delerive P, Maliszewski C, Capron M, Staels B, Moser M, Trottein F: Peroxisome proliferator-activated receptor gamma activators inhibit interleukin-12 production in murine dendritic cells.\nFEBS Lett 2000, 486:261\u2013266.","journal-title":"FEBS Lett"},{"key":"370_CR33_370","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1002\/1521-4141(2000012)30:12<3363::AID-IMMU3363>3.0.CO;2-B","volume":"30","author":"H Sugiyama","year":"2000","unstructured":"Sugiyama H, Nonaka T, Kishimoto T, Komoriya K, Tsuji K, Nakahata T: Peroxisome proliferator-activated receptors are expressed in human cultured mast cells: a possible role of these receptors in negative regulation of mast cell activation.\nEur J Immunol 2000, 30:3363\u20133370.","journal-title":"Eur J Immunol"},{"key":"370_CR34_370","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0014-5793(00)01169-8","volume":"467","author":"H Sugiyama","year":"2000","unstructured":"Sugiyama H, Nonaka T, Kishimoto T, Komoriya K, Tsuji K, Nakahata T: Peroxisome proliferator-activated receptors are expressed in mouse bone marrow-derived mast cells.\nFEBS Lett 2000, 467:259\u2013262.","journal-title":"FEBS Lett"},{"key":"370_CR35_370","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1128\/IAI.67.7.3488-3493.1999","volume":"67","author":"MR Hill","year":"1999","unstructured":"Hill MR, Clarke S, Rodgers K, Thornhill B, Peters JM, Gonzalez FJ, Gimble JM: Effect of peroxisome proliferator-activated receptor alpha activators on tumor necrosis factor expression in mice during endotoxemia.\nInfect Immun 1999, 67:3488\u20133493.","journal-title":"Infect Immun"},{"key":"370_CR36_370","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.4049\/jimmunol.164.2.1046","volume":"164","author":"R Thieringer","year":"2000","unstructured":"Thieringer R, Fenyk-Melody JE, Le Grand CB, Shelton BA, Detmers PA, Somers EP, Carbin L, Moller DE, Wright SD, Berger J: Activation of peroxisome proliferator-activated receptor gamma does not inhibit IL-6 or TNF-alpha responses of macrophages to lipopolysaccharide in vitro or in vivo.\nJ Immunol 2000, 164:1046\u20131054.","journal-title":"J Immunol"},{"key":"370_CR37_370","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1046\/j.1365-2133.2003.05532.x","volume":"149","author":"S Kuenzli","year":"2003","unstructured":"Kuenzli S, Saurat JH: Peroxisome proliferator-activated receptors in cutaneous biology.\nBr J Dermatol 2003, 149:229\u2013236.","journal-title":"Br J Dermatol"},{"key":"370_CR38_370","first-page":"1131","volume":"53","author":"I Wiesenberg","year":"1998","unstructured":"Wiesenberg I, Chiesi M, Missbach M, Spanka C, Pignat W, Carlberg C: Specific activation of the nuclear receptors PPARgamma and RORA by the antidiabetic thiazolidinedione BRL 49653 and the antiarthritic thiazolidinedione derivative CGP 52608.\nMol Pharmacol 1998, 53:1131\u20131138.","journal-title":"Mol Pharmacol"},{"key":"370_CR39_370","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0092-8674(00)81567-6","volume":"93","author":"BM Spiegelman","year":"1998","unstructured":"Spiegelman BM: PPARgamma in monocytes: less pain, any gain?\nCell 1998, 93:153\u2013155.","journal-title":"Cell"},{"key":"370_CR40_370","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/83336","volume":"7","author":"A Chawla","year":"2001","unstructured":"Chawla A, Barak Y, Nagy L, Liao D, Tontonoz P, Evans RM: PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation.\nNat Med 2001, 7:48\u201352.","journal-title":"Nat Med"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-6-132.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1465-9921-6-132\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-6-132","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-6-132.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T09:38:48Z","timestamp":1630489128000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/1465-9921-6-132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,7]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["370"],"URL":"https:\/\/doi.org\/10.1186\/1465-9921-6-132","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,7]]},"assertion":[{"value":"3 April 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"132"}}